SCHEMBL17353218

SCHEMBL17353218

CC(=O)OC1CNC(c2cc(F)ccc2OC2CCOCC2)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KAT2B Q92831 1/20 0.39
BAZ2B Q9UIF8 1/20 0.39
NTRK1 P04629 2/20 0.39
PDE4D Q08499 6/20 0.37
PDE4A P27815 4/20 0.37
PDE4B Q07343 4/20 0.37
PDE4C Q08493 4/20 0.37
SYK P43405 1/20 0.37
PSEN1 P49768 1/20 0.36
PSEN2 P49810 1/20 0.36
APH1B Q8WW43 1/20 0.36
NCSTN Q92542 1/20 0.36
APH1A Q96BI3 1/20 0.36
PSENEN Q9NZ42 1/20 0.36
GPR6 P46095 1/20 0.34
GRIK1 P39086 2/20 0.34
GRIA2 P42262 2/20 0.34
GRM5 P41594 1/20 0.34
SLC6A4 P31645 1/20 0.33
HTR3A P46098 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17353217 1.00 KAT2B (0.39) KAT2BBAZ2BNTRK1PDE4DPDE4A
SCHEMBL17353212 0.94 PDE4D (0.40) NTRK1PDE4DPDE4APDE4BPDE4C
SCHEMBL17353178 0.94 PDE4D (0.40) NTRK1PDE4DPDE4APDE4BPDE4C
SCHEMBL431665 0.78 PRKAG1 (0.36)
SCHEMBL448825 0.78 PRKAG1 (0.36)
SCHEMBL17928300 0.75 NTRK1 (0.36) NTRK1PDE4DPDE4APDE4BPDE4C
SCHEMBL17358820 0.75 NTRK1 (0.36) NTRK1PDE4DPDE4APDE4BPDE4C
Hydrochloric Acid SCHEMBL17353141 0.74 NTRK1 (0.36) NTRK1PDE4DPDE4APDE4BPDE4C
SCHEMBL17376592 0.73 PDE4D (0.42) NTRK1PDE4DPDE4APDE4BPDE4C
SCHEMBL17376591 0.73 PDE4D (0.42) NTRK1PDE4DPDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9782391-B2 Substituted imidazo[1,2-a]pyridine compounds as tropomyosin receptor kinase a (TrkA) inhibitors DR. REDDY'S LABORATORIES LTD. (IN) 2017-10-10 US disclosed
EP-3157921-A1 SUBSTITUTED IMIDAZO[1,2-A]PYRIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF PAIN Dr. Reddy's Laboratories Ltd. (IN) 2017-04-26 EP disclosed
US-20160279109-A1 SUBSTITUTED IMIDAZO[1,2-a]PYRIDINE COMPOUNDS AS TROPOMYOSIN RECEPTOR KINASE A (TrkA) INHIBITORS DR. REDDY'S LABORATORIES LTD. (IN) 2016-09-29 US disclosed
US-9394305-B2 Substituted imidazo[1,2-a]pyridine compounds as tropomyosin receptor kinase a (TrkA) inhibitors DR. REDDY'S LABORATORIES LTD. (IN) 2016-07-19 US disclosed
WO-2015200341-A1 SUBSTITUTED IMIDAZO[1,2-A]PYRIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF PAIN DR. REDDY'S LABORATORIES LTD. (IN) 2015-12-30 WO disclosed
US-20150368238-A1 SUBSTITUTED IMIDAZO[1,2-a]PYRIDINE COMPOUNDS AS TROPOMYOSIN RECEPTOR KINASE A (TrkA) INHIBITORS DR. REDDY'S LABORATORIES LTD. (IN) 2015-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160279109-A1 SUBSTITUTED IMIDAZO[1,2-a]PYRIDINE COMPOUNDS AS TROPOMYOSIN RECEPTOR KINASE A (TrkA) INHIBITORS NTRK1, NTRK3, MUSK KAT2B 4692/4885BAZ2B 2313/4885NTRK1 1/4885
US-20150368238-A1 SUBSTITUTED IMIDAZO[1,2-a]PYRIDINE COMPOUNDS AS TROPOMYOSIN RECEPTOR KINASE A (TrkA) INHIBITORS NTRK1, NTRK3, MUSK KAT2B 4692/4885BAZ2B 2313/4885NTRK1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.